NEW YORK (GenomeWeb News) — Bruker BioSciences today said fourth-quarter revenues increased 27 percent as R&D spending rose 23 percent and profit nearly doubled.
Total receipts for the three months ended Dec. 31, 2006, increased to $135.6 million from $106.7 million year over year.
Product revenue increased 25 percent to $120.4 million; service revenue increased 45 percent to $15 million; and “other” revenue decreased 48 percent to $146,000.
CEO Frank Laukien said the acquisition of Bruker Optics and other expansions added to revenue for the year. He said the company “continued to strengthen both our traditional research systems business and our newer industrial and applied analysis business,” and added that the fourth quarter was “particularly strong.”
Bruker said profit surged 98 percent to $9.7 million from $4.9 million in the year-ago period.
Bruker said it had around $52.7 million in cash and equivalents and short-term investments as of Dec. 31.
Laukien said the company expects revenue to grow more than 10 percent in 2007.